Does CERITINIB Cause Therapy non-responder? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Therapy non-responder have been filed in association with CERITINIB (ZYKADIA). This represents 0.4% of all adverse event reports for CERITINIB.
10
Reports of Therapy non-responder with CERITINIB
0.4%
of all CERITINIB reports
2
Deaths
0
Hospitalizations
How Dangerous Is Therapy non-responder From CERITINIB?
Of the 10 reports, 2 (20.0%) resulted in death, and 1 (10.0%) were considered life-threatening.
Is Therapy non-responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CERITINIB. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does CERITINIB Cause?
Malignant neoplasm progression (523)
Diarrhoea (452)
Death (391)
Nausea (381)
Vomiting (270)
Metastases to central nervous system (203)
Non-small cell lung cancer (183)
Fatigue (149)
Decreased appetite (139)
Dyspnoea (137)
What Other Drugs Cause Therapy non-responder?
ETANERCEPT (3,472)
APREMILAST (3,360)
METHOTREXATE (2,965)
RITUXIMAB (2,731)
ADALIMUMAB (2,595)
PREDNISONE (2,563)
TREPROSTINIL (2,289)
INFLIXIMAB (2,122)
TOCILIZUMAB (1,775)
HYDROXYCHLOROQUINE (1,699)
Which CERITINIB Alternatives Have Lower Therapy non-responder Risk?
CERITINIB vs CERLIPONASE ALFA
CERITINIB vs CERTICAN
CERITINIB vs CERTOLIZUMAB
CERITINIB vs CERTOLIZUMAB PEGOL
CERITINIB vs CERTOPARIN